Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

American Family Physician July 1, 2001 Selim R. Benbadis	Advances in the Treatment of Epilepsy Significant advances have been made in the diagnosis and treatment of epilepsy over the past decade...
Nursing September 1, 2007 Mary Unruh Fagley	Taking Charge of Seizure Activity Learn what happens during a seizure when the brain's electric signals go awry and how you can help someone plagued by the disturbing effects.
American Family Physician August 1, 2003 Sirven & Waterhouse	Management of Status Epilepticus Physicians should rely on a standardized protocol for management of status epilepticus to improve care for this neurologic emergency.
American Family Physician September 1, 2000 Gary N. McAbee & James E. Wark	A Practical Approach to Uncomplicated Seizures in Children Uncomplicated seizures and epilepsy are common in infants and children. Not all uncomplicated childhood seizures require neuroimaging or treatment...
Nursing February 2010 Daniel A. Hussar	New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs.
American Family Physician May 15, 2006 James S. Millar	Evaluation and Treatment of the Child with Febrile Seizure Up to 5% of children in North America and western Europe experience at least one episode of febrile seizure before six years of age. Most of these seizures are self-limited and patients do not require treatment.
Nursing June 2010 Daniel A. Hussar	New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs.
American Family Physician September 1, 2005 Alsaadi & Marquez	Psychogenic Nonepileptic Seizures Often misdiagnosed and treated for epilepsy, these seizures are unique in that they do not have a neurologic origin.
American Family Physician October 15, 2002 Martha J. Morrell	Epilepsy in Women Epilepsy in women raises special reproductive and general health concerns. Seizure frequency and severity may change at puberty, over the menstrual cycle, with pregnancy, and at menopause.
Nursing June 2011 Daniel A. Hussar	New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis.
Nursing March 2012 Daniel A. Hussar	New Drugs 2012: part I In this article, you'll learn about 11 recently approved drugs.
Nursing May 2012 Tim Blake	Three Medication Pathways for Bipolar Disorder No matter where you work, you're likely to care for patients with bipolar disorder, which affects about 2.6% of people age 18 and older per year.
American Family Physician November 15, 2002 Cynthia M. Williams	Using Medications Appropriately in Older Adults Finding the right balance between too few and too many drugs will help ensure increased longevity, improved overall health, and enhanced functioning and quality of life for the aging population.
Nurse Practitioner February 2012 Jennifer M. Belavic	Annual drug update 2011 in review Many new medications were approved throughout 2011. This article will cover a variety of drugs that will be useful in nurse practitioner practice
Nurse Practitioner February 2011 Jennifer M. Belavic	Annual Drug Update: 2010 in Review In 2010, the FDA approved several new drugs and new indications for use in primary care. From new therapies for adults with rheumatoid arthritis to a combination drug for benign prostatic hyperplasia, NPs need to be aware of the latest medications now available.
American Family Physician February 1, 2005 Maizels & McCarberg	Antidepressants and Antiepileptic Drugs for Chronic Non-Cancer Pain The development of newer classes of antidepressants and second-generation antiepileptic drugs has created unprecedented opportunities for the treatment of chronic pain. These drugs modulate pain transmission by interacting with specific neurotransmitters and ion channels.
Nursing June 2011 Cahill & Armstrong	Caring for an adult with a malignant primary brain tumor Pprimary brain tumors are relatively uncommon, occurring in an estimated 63,000 patients in the united states each year.
Nursing February 2009 Daniel A. Hussar	New Drugs 09: Part 1 Learn about 10 new drugs, including nebivolol HCl, the newest beta-adrenergic blocking agent for hypertension.
American Journal of Nursing May 2012 Wright et al.	Posterior Reversible Encephalopathy Syndrome: A Case Study Posterior reversible encephalopathy syndrome is a rare neurologic disorder characterized by an acute increase in blood pressure, and by headaches, altered mental status, seizures, and visual loss.
American Family Physician February 1, 2005 Richard D. Blondell	Ambulatory Detoxification of Patients with Alcohol Dependence An appropriate candidate for outpatient detoxification should have arrangements to start an alcohol treatment program and a responsible support person who can monitor progress, and should not have significant, acute, comorbid conditions or risk factors for severe withdrawal.
Nursing April 2012 Elliott et al.	Managing alcohol withdrawal in hospitalized patients A focused nursing assessment is critical in identifying the potential for alcohol withdrawal symptoms in all hospitalized patients. This article discusses how to assess patients at risk and how to use these assessment findings as a basis for nursing interventions.
American Family Physician March 15, 2004	Alcohol Withdrawal Syndrome The spectrum of alcohol withdrawal symptoms ranges from such minor symptoms as insomnia and tremulousness to severe complications such as withdrawal seizures and delirium tremens. This article covers evaluation and treatment of the patient.
American Journal of Nursing November 2011 Christine L. Cutugno	The 'Graying' of Trauma Care: Addressing Traumatic Injury in Older Adults Evidence-based strategies for managing trauma and its complications in this population.
Nursing March 2011 Mink & Miller	Stroke, Part 2: Respond aggressively to hemorrhagic stroke Patients may arrive at the hospital any time from minutes to days after a hemorrhagic stroke, and nurses need to be prepared for the unique challenges associated with their care.
Nursing March 2010 Peg Gray-Vickrey	Gathering pearls of knowledge for assessing older adults If you attended nursing school more than 10 years ago, you may have received limited education about gerontological nursing. But as baby boomers age, this is becoming an increasingly important area of nursing practice.
Nursing August 2010 Bartley & Shiflett	Handle older trauma patients with care Your comprehensive understanding of how age-related changes can affect outcomes during and after trauma will help your patients recover to the fullest extent possible.
American Family Physician May 15, 2006	Febrile Seizures: What You Should Know A patient guide: What are febrile seizures?... Who gets febrile seizures and why?... How can my doctor tell if my child has had a febrile seizure?... What can I expect?... etc.
American Family Physician July 1, 2001	What Should I Know About Seizures and Epilepsy? What is a seizure, and what is epilepsy?... What causes epilepsy?... Who gets epilepsy?... Are all seizures the same?... How does the doctor find out I have epilepsy?...
American Family Physician June 15, 2006 Prater & Zylstra	Medical Care of Adults with Mental Retardation Primary medical care of persons with mental retardation should involve continuity of care, maintenance of comprehensive treatment documentation, routine periodic health screening, and an understanding of the unique medical and behavioral disorders common to this population.
Pharmaceutical Executive April 1, 2011	Off-Label But On Point? Use of off-label drugs is a balancing act for physicians, and poses even more problems for pharma. The FDA is moving slowly to help.
American Family Physician October 15, 2005 Huntington & Yuan	Topiramate (Topamax) for Migraine Prevention Topiramate is more effective than placebo for migraine prevention. Its effectiveness appears to be similar to that of other antiepileptic drugs and beta blockers.
The Motley Fool June 14, 2011 Frank Vinluan	GSK Epilepsy Drug Approved by FDA GlaxoSmithKline and drug partner Valeant Pharmaceuticals have received U.S. Food and Drug Administration approval on a new epilepsy drug, but it must be classified as a controlled substance.
Chemistry World March 7, 2011 Russell Johnson	Breathe out for personalised medicine A method to analyse drug levels in the body could allow people with epilepsy to avoid weeks of blood tests, claim scientists from Switzerland.
Managed Care March 2008 Martin Sipkoff	The Epilepsy Battle in the War Between Brands and Generics Brand-name manufacturers and many neurologists see danger in generic substitution, but the FDA insists that the practice is safe
Reactive Reports July 2004 David Bradley	Breaking the Cycle of Epilepsy in Women Researchers have made an important discovery about a form of epilepsy that affects women most severely during menstruation. The findings could lead to a new treatment based on manipulating levels of the hormone progesterone.
The Motley Fool August 10, 2010 Brian Orelli	When the Disease Matters Most in Drug Approval Glaxo's and Valeant's Potiga will go before an FDA advisory committee tomorrow.
The Motley Fool August 10, 2010 Ryan McBride	Vertex's Telaprevir Clears Hurdle, Could Halve Treatment Times for Hepatitis C Study results are positive.
Pharmaceutical Executive November 1, 2013 Ben Comer	Top Medical Innovations for 2014 At the conclusion of the Cleveland Clinic's Medical Innovations Summit each year, 10 innovative technologies are unveiled before the audience, and designated as new and revolutionary tools for the treatment of disease and disability.
IEEE Spectrum May 2005 Samuel K. Moore	Zapping Away The Blues Cyberonics Inc. plans to introduce the first implanted device that can treat a psychiatric illness.
IEEE Spectrum March 2006 Samuel K. Moore	Psychiatry's Shocking New Tools Electronic implants and electromagnetic pulses are picking up where psychoactive drugs have failed.
BusinessWeek March 7, 2005 Michael Arndt	Rewiring The Body First came pacemakers. Now exotic implants are bringing new hope to victims of epilepsy, paralysis, depression, and other diseases. And some of the biggest names in health care are in a scramble to get into the market.
Chemistry World November 2010	Column: In the Pipeline Should drug companies focus on big markets and the blockbuster dream?
IEEE Spectrum June 2009 Virginia Hughes	A New Approach to Predicting Epileptic Seizures Torrents of data produced by implanted microelectrodes could finally yield a prediction system
BusinessWeek October 1, 2009	Stalking the Future J&J lost patent protection on epilepsy and schizophrenia drugs worth $7 billion last year. These new drugs, if cleared by the FDA, could help offset the damage.
The Motley Fool February 18, 2010 Brian Orelli	Still Restless for an Approval The FDA is like a box of chocolates: You never know what you're going to get -- rejection or acceptance.
The Motley Fool March 31, 2011 Brian Orelli	Drug Warning Labels: The Good, Bad, and Ugly Once a drug is approved, investors can't fall asleep and ignore FDA announcements about drugs. They come in different varieties, but warnings tend to be of the bad and ugly variety more often than the good.
The Motley Fool February 16, 2010 Brian Orelli	For Blockbuster Cancer Drugs, Approvals Are the Easy Part Don't get too excited. As an investor, you can lower your risk by investing in cancer drug companies after a clinical trial success but before an FDA approval, but you'll also reduce your reward.